No abstract

We analysed relationships between demersal fish species richness, environment and trawl characteristics using an extensive collection of trawl data from the oceans around New Zealand. Analyses were carried out using both generalised additive models and boosted regression trees (sometimes referred to as 'stochastic gradient boosting'). Depth was the single most important environmental predictor of variation in species richness, with highest richness occurring at depths of 900 to 1000 m, and with a broad plateau of moderately high richness between 400 and 1100 m. Richness was higher both in waters with high surface concentrations of chlorophyll a and in zones of mixing of water bodies of contrasting origins. Local variation in temperature was also important, with lower richness occurring in waters that were cooler than expected given their depth. Variables describing trawl length, trawl speed, and cod-end mesh size made a substantial contribution to analysis outcomes, even though functions fitted for trawl distance and cod-end mesh size were constrained to reflect the known performance of trawl gear. Species richness declined with increasing cod-end mesh size and increasing trawl speed, but increased with increasing trawl distance, reaching a plateau once trawl distances exceed about 3 nautical miles. Boosted regression trees provided a powerful analysis tool, giving substantially superior predictive performance to generalized additive models, despite the fitting of interaction terms in the latter.

Eight weeks administration of resveratrol did not significantly improve any features of NAFLD, compared with placebo, but it increased hepatic stress, based on observed increases in levels of liver enzymes. Further studies are needed to determine whether agents that are purported to mimic calorie restriction, such as resveratrol, are safe and effective for complications of obesity. Clinical trials registration no: ACTRN12612001135808.

Background-Numerous in vitro studies suggest that sphingosine 1-phosphate (S1P), a bioactive lysosphingolipid associated with high-density lipoproteins, accounts at least partly for the potent antiinflammatory properties of high-density lipoprotein and, thereby, contributes to the antiatherogenic potential attributed to high-density lipoproteins. The present study was undertaken to investigate whether modulation of S1P signaling would affect atherosclerosis in a murine model of disease. Methods and Results-Low-density lipoprotein receptor-deficient mice on a cholesterol-rich diet were given FTY720, a synthetic S1P analogue, at low (0.04 mg/kg per day) or high (0.4 mg/kg per day) doses for 16 weeks. FTY720 dose-dependently reduced atherosclerotic lesion formation, both in the aortic root and brachiocephalic artery, and almost completely blunted necrotic core formation. Plasma lipids remained unchanged during the course of FTY720 treatment. However, FTY720 lowered blood lymphocyte count (at a high dose) and significantly interfered with lymphocyte function, as evidenced by reduced splenocyte proliferation and interferon-␥ levels in plasma. Plasma concentrations of proinflammatory cytokines such as tumor necrosis factor-␣, interleukin (IL)-6, IL-12, and regulated on activation normal T cell expressed and secreted were reduced by FTY720 administration. Moreover, lipopolysaccharide-elicited generation of nitrite/nitrate and IL-6 -two markers of classical (M1) macrophage activation-was inhibited, whereas IL-4 -induced production of IL-1-receptor antagonist, a marker of alternative (M2) macrophage activation, was augmented in peritoneal macrophages from FTY720-treated low-density lipoprotein receptor-deficient mice. Conclusions-The present results demonstrate that an S1P analogue inhibits atherosclerosis by modulating lymphocyte and macrophage function, and these results are consistent with the notion that S1P contributes to the antiatherogenic potential of high-density lipoprotein. (Circulation. 2007;115:501-508.)